News
A meta-analysis published in JAMA Dermatology confirmed which hidradenitis suppurativa treatments elicit the best ...
Zacks Investment Research on MSN12h
Will Key Drugs Maintain Momentum for Novartis in Q2 Earnings?Novartis AG NVS, a Swiss pharma giant, is scheduled to report second-quarter 2025 results on July 17. The Zacks Consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback